TipHub

0.47

-0.01 -2.08%

As of 29 Jul 2026 · delayed

BSE Listed

GSM · GSM 0 · LT-ASM · ASM 1
What does GSM · GSM 0 · LT-ASM · ASM 1 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-06-25
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-04-29

Johnson Pharmacare Limited (532154)

Volume: 5,19,129Avg Vol 1W: 6,54,537Avg Vol 1M: 5,82,23752W Range:0.460.85
Market Cap₹26 Cr
Current Price₹0.47
Previous Close₹0.48
High / Low (52w)₹0.85 / ₹0.46
Volume5,19,129
Avg Vol (1W)6,54,537
Avg Vol (1M)5,82,237
Stock P/E
Book Value₹0.01
Dividend Yield0%
ROE-9,527.55%
ROA-252.93%
Revenue (TTM)
Revenue Growth
Profit Margin0%
Total Debt
Shares Outstanding55 Cr
Face Value
EPS (TTM)₹0
P/B58.75
Debt / Equity0.02
50 DMA₹0.51
200 DMA₹0.56
Day change-2.08%
SurveillanceGSM · GSM 0 · LT-ASM · ASM 1
Price Chart
0.47 43.37% · 1Y
1032.1L
2025-07-30
2026-07-29

20-day avg volume: 5.7L shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-41 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹-56 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹3 Cr₹3 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr
EPS-0.01-0-0.0200-0.02-0-0.01
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹60 Cr₹60 Cr₹60 Cr₹58 Cr
Total Liabilities₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr
Equity₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹57 Cr₹57 Cr₹56 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹5 Cr₹0 Cr₹0 Cr₹-2 Cr
Investing₹0 Cr₹-5 Cr₹-1 Cr₹0 Cr₹3 Cr
Financing₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹-1 Cr
Free Cash Flow₹0 Cr₹5 Cr₹0 Cr₹0 Cr₹-2 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE-188.7%
Interest Coverage0
Dividend Payout
Debtor Days
Inventory Days
Payable Days
Cash Conversion Cycle
Working Capital Days
Shareholding Details

As of 2026-06-30

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge
No. of Shareholders1,17,101
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public100%100%100%100%100%100%100%100%100%100%100%100%
Promoter Pledge
No. of Shareholders1,16,9651,16,9711,16,9261,16,9011,17,3971,17,1011,17,1051,17,0981,17,1011,17,1011,17,1011,17,101
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Jagkarta Agencies Private LimitedPublic Shareholding2.8%1.53 Cr
Apex Commotrade Private LimtiedPublic Shareholding1.8%1.01 Cr
Spice Merchants Private LimitedPublic Shareholding1%55,60,894
Board of Directors
NameDesignationYear
Ramanlal TrivediChairman & WTD & CFO2025
Pareshbhai SengalIndependent Director2025
Manisha Maneklal PatelIndependent Director2025
BabitaIndependent Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1555555
Substantial Acquisitions (SAST)

1 disclosure(s)

Off Market17/12/2021 · 26,73,800
Company Information
Incorporated1994
ChairmanRamanlal Trivedi
AuditorRishi Sekhri & Associates
Investor Email[email protected]
🌐 www.johnsonpharmacareltd.shop

📍 Office No 302 Munisuvrat Navg, NTC B-68 Swastik Society CG Rd, Ahmedabad, Gujarat, 380009

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search